{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:45:06Z","timestamp":1787071506104,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Central sensitization syndromes and neuropathic pain are frequently associated with chronic inflammatory rheumatic diseases such as psoriasis and psoriatic arthritis (PsA). Here, we analyzed the clinical significance of central sensitization (CS) and neuropathic pain, defined as the hyperexcitability of the central nervous system, in psoriasis and PsA patients. Our study included 50 patients with psoriasis aged 45.3 \u00b1 14.4 years, 53 PsA patients aged 41.4 \u00b1 12.7 years, and 50 healthy control group aged 40.7 \u00b1 13.5 years (with similar age and body mass index distribution). Visual analogue scale (VAS), psoriasis area and severity index (PASI) score, health assessment questionnaire (HAQ), minimal disease activity (MDA) scale, self-leeds assessment of neuropathic symptom and signs (S_LANNS), pain-detect questionnaire, and central sensitization inventory (CSI) were used in the study. The presence of CS was in the 68% of patients with psoriasis (N = 34), 35.8% (N = 19) of PsA patients, and 63.6% (N = 21) in control group; neuropathic pain was detected 50% of patients with psoriasis (N = 25), 60.4% (N = 32) of PsA patients, and 63.6% (N = 21) in controls. Frequencies of most common central sensitization syndromes were as follows: anxiety disorder (48%), chronic fatigue syndrome (40%), restless leg syndrome (22%), and depression (22%) in the psoriasis group and chronic fatigue syndrome (39.6%), fibromyalgia syndrome (28.3%), and irritable bowel syndrome (18.9%) in the psoriatic arthritis group. In the linear logistic regression analysis, MDA was found to be strongly related with the CS score (beta = -0.534;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001). Neuropathic pain and CS are frequently associated with disease activity in psoriasis and PsA patients. These chronic pain syndromes should be considered in management of these diseases.\n                  <\/jats:p>","DOI":"10.4103\/ijd.ijd_319_23","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:00:15Z","timestamp":1764248415000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Importance of Central Sensitization and Neuropathic Pain in The Treatment and Follow-Up of Patients with Psoriasis and Psoriatic Arthritis"],"prefix":"10.4103","volume":"71","author":[{"given":"Tuba T\u00fclay","family":"Koca","sequence":"first","affiliation":[{"name":"From the Department of Physical Medicine and Rehabilitation, S\u00fct\u00e7\u00fc \u0130mam University, Faculty of Medicine, Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"G\u00f6\u011febakan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, S\u00fct\u00e7\u00fc \u0130mam University, Faculty of Medicine, Division of Rheumatology, Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fclya","family":"Nazik","sequence":"additional","affiliation":[{"name":"Department of Dermatology, S\u00fct\u00e7\u00fc \u0130mam University, Faculty of Medicine, Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6zde","family":"\u00c7etin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, S\u00fct\u00e7\u00fc \u0130mam University, Faculty of Medicine, Division of Rheumatology, Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perihan","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Dermatology, S\u00fct\u00e7\u00fc \u0130mam University, Faculty of Medicine, Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20251231","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology:Current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R2-20251231","first-page":"525","article-title":"Skin and brain:\u0130tch and psychiatric disorders","volume":"151","author":"Caccavale","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"R3-20251231","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1529-8019.2008.00167.x","article-title":"Neuropathic and psychogenic itch","volume":"21","author":"Yosipovitch","year":"2008","journal-title":"Dermatol Ther"},{"key":"R4-20251231","doi-asserted-by":"crossref","first-page":"108397","DOI":"10.1016\/j.clim.2020.108397","article-title":"Comorbidities associated with psoriatic arthritis:Review and update","volume":"214","author":"Perez-Chada","year":"2020","journal-title":"Clin Immunol"},{"key":"R6-20251231","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0079-6123(08)60452-5","article-title":"The glutamate synapse:A target in the pharmacological management of hyperalgesic pain states","volume":"116","author":"Urban","year":"1998","journal-title":"Prog Brain Res"},{"key":"R7-20251231","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3899\/jrheum.160111","article-title":"Attainment of minimal disease activity using methotrexate in psoriatic arthritis","volume":"43","author":"Sheane","year":"2016","journal-title":"J Rheumatol"},{"key":"R8-20251231","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpain.2004.11.007","article-title":"The S-LANSS score for identifying pain of predominantly neuropathic origin:Validation for use in clinical and postal research","volume":"6","author":"Bennett","year":"2005","journal-title":"J Pain"},{"key":"R9-20251231","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1185\/03007995.2016.1157460","article-title":"The painDETECT project-far more than a screening tool on neuropathic pain","volume":"32","author":"Freynhagen","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"R10-20251231","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.spinee.2017.06.008","article-title":"Use of the central sensitization \u0131nventory (CSI) as a treatment outcome measure for patients with chronic spinal pain disorder in a functional restoration program","volume":"17","author":"Neblett","year":"2017","journal-title":"Spine J"},{"key":"R11-20251231","doi-asserted-by":"crossref","first-page":"e001002","DOI":"10.1136\/rmdopen-2019-001002","article-title":"Measurement properties of the minimal disease activity criteria for psoriatic arthritis","volume":"5","author":"Coates","year":"2019","journal-title":"RMD Open"},{"key":"R12-20251231","article-title":"Validity and Reliability of the Central Sensitization Scale","author":"D\u00fczce","year":"2017","journal-title":"Thesis. Trakya University, Department of Physical Medicine and Rehabilitation"},{"key":"R13-20251231","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1468-3083.2009.03562.x","article-title":"What are the best outcome measures for assessing plaque psoriasis severity?A systematic review of the literature","volume":"24","author":"Puzenat","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-20251231","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jbspin.2015.07.017","article-title":"Fatigue in psoriatic arthritis-A cross -sectional study of 246 patients from 13 countries","volume":"83","author":"Gudu","year":"2016","journal-title":"Joint Bone Spine"},{"key":"R15-20251231","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2014-206824","article-title":"On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis:Population-based data from the Nord-Tr\u00f8ndelag health study","volume":"75","author":"Gulati","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R16-20251231","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3899\/jrheum.181412","article-title":"Relationship between fatigue and inflammation, disease duration, and chronic pain in psoriatic arthritis:An observational DANBIO registry study","volume":"47","author":"Skougaard","year":"2020","journal-title":"J Rheumatol"},{"key":"R17-20251231","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","article-title":"Fibromyalgia in patients with axial spondyloarthritis:Epidemiological profile and effect on measures of disease activity","volume":"34","author":"Salaffi","year":"2014","journal-title":"Rheumatol Int"},{"key":"R18-20251231","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3899\/jrheum.110893","article-title":"Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia","volume":"39","author":"Marchesoni","year":"2012","journal-title":"J Rheumatol"},{"key":"R19-20251231","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3899\/jrheum.120798","article-title":"Differentiation of the clinical features of psoriatic arthritis and fibromyalgia","volume":"39","author":"Konno","year":"2012","journal-title":"J Rheumatol"},{"key":"R20-20251231","doi-asserted-by":"crossref","first-page":"105399","DOI":"10.1016\/j.jbspin.2022.105399","article-title":"Assessing central sensitization with quantitative sensory testing in inflammatory rheumatic diseases:A systematic review","volume":"89","author":"Trouvin","year":"2022","journal-title":"Joint Bone Spine"},{"key":"R21-20251231","doi-asserted-by":"crossref","first-page":"1759720X21993252","DOI":"10.1177\/1759720X21993252","article-title":"Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?","volume":"13","author":"Adami","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R22-20251231","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.24430","article-title":"Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis","volume":"61","author":"Ranzolin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R23-20251231","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.rbr.2016.11.004","article-title":"Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia","volume":"57","author":"Chakr","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"R24-20251231","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpsychores.2018.12.010","article-title":"Central sensitization in chronic pain and medically unexplained symptom research:A systematic review of definitions, operationalizations and measurement instruments","volume":"117","author":"den Boer","year":"2019","journal-title":"J Psychosom Res"},{"key":"R25-20251231","doi-asserted-by":"crossref","first-page":"e0180014","DOI":"10.1371\/journal.pone.0180014","article-title":"Pain and pain mechanisms in patients with inflammatory arthritis:A Danish nationwide cross-sectional DANBIO registry survey","volume":"12","author":"Rifbjerg-Madsen","year":"2017","journal-title":"PLoS One"},{"key":"R26-20251231","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12955-017-0681-1","article-title":"Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis:Rasch analysis and test-retest reliability","volume":"15","author":"Rifbjerg-Madsen","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"R27-20251231","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1756-185X.13553","article-title":"Systematic review of depression and anxiety in psoriatic arthritis","volume":"22","author":"Kamalaraj","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"R28-20251231","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"key":"R29-20251231","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/09546634.2018.1466023","article-title":"Assessment of psoriasis severity in Brazilian patients with chronic plaque psoriasis attending outpatient clinics:A multicenter, population-based cross-sectional study (APPISOT)","volume":"29","author":"Romiti","year":"2018","journal-title":"J Dermatolog Treat"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_319_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:08Z","timestamp":1787068028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_319_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_319_23","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"2023-03-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}